Gedivumab - CAS 1807954-17-1

Gedivumab (MHAA4549A; RG7745), a human monoclonal antibody, exhibits high specificity in targeting the influenza A virus (IAV) by binding to the highly conserved stem region of the IAV hemagglutinin protein. This interaction inhibits hemagglutinin maturation and blocks hemagglutinin-mediated membrane fusion within the intranucleosome, making Gedivumab useful for studies on IAV infection disease [1].

Influenza Virus

Microbiology/Virology

1807936

-20°C

Ice Packs

Inhibitory Antibodies